Combined doxorubicin and alpha-interferon therapy of advanced hepatocellular carcinoma
Open Access
- 1 April 1993
- Vol. 71 (7), 2187-2190
- https://doi.org/10.1002/1097-0142(19930401)71:7<2187::aid-cncr2820710704>3.0.co;2-j
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- A prospective trial of recombinant human interferon alpha 2B in previously untreated patients with hepatocellular carcinomaCancer, 1990
- Hepatoma in the noncirrhotic liverCancer, 1988
- Treatment of hepatocellular carcinoma with recombinant leucocyte interferon: A pilot studyBritish Journal of Cancer, 1985
- Primary hepatocellular cancer—present results and future prospectsInternational Journal of Radiation Oncology*Biology*Physics, 1983
- Combined interferon-antimetabolite therapy of murine L1210 leukemiaCancer, 1981
- Identification of integrated hepatitis B virus DNA and expression of viral RNA in an HBsAg-producing human hepatocellular carcinoma cell lineNature, 1980
- Chemotherapy studies in primary liver cancer. A prospective randomized clinical trialCancer, 1978
- A phase II study of adriamycin (NSC 123127) in patients with hepatocellular carcinoma from Zambia and the United StatesCancer, 1977
- Interferon and murine leukemia. VII. Therapeutic effect of interferon preparations after diagnosis of lymphoma in akr miceInternational Journal of Cancer, 1976
- Treatment of hepatocellular carcinoma with adriamycin.Preliminary communicationCancer, 1975